A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virus.

[1]  Douglas M Smith,et al.  A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge. , 2019, Vaccine.

[2]  F. Krammer.  The human antibody response to influenza A virus infection and vaccination , 2019, Nature Reviews Immunology.

[3]  G. Alter,et al.  Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine , 2019, Front. Immunol..

[4]  Su He Wang,et al.  Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge. , 2019, Vaccine.

[5]  G. Gao,et al.  ID2 and ID3 are indispensable for Th1 cell differentiation during influenza virus infection in mice , 2019, European journal of immunology.

[6]  D. Cho,et al.  Lysyl–Transfer RNA Synthetase Induces the Maturation of Dendritic Cells through MAPK and NF-κB Pathways, Strongly Contributing to Enhanced Th1 Cell Responses , 2018, The Journal of Immunology.

[7]  B. Kinzel,et al.  Interferon regulatory factor 5 and nuclear factor kappa‐B exhibit cooperating but also divergent roles in the regulation of pro‐inflammatory cytokines important for the development of TH1 and TH17 responses , 2018, The FEBS journal.

[8]  Jin Hyang Kim,et al.  Extensive T cell cross-reactivity between diverse seasonal influenza strains in the ferret model , 2018, Scientific Reports.

[9]  E. B. Clemens,et al.  Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine , 2018, Vaccines.

[10]  S. Pillet,et al.  A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response , 2017, Clinical and Vaccine Immunology.

[11]  Thomas P. Fabrizio,et al.  The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants , 2017, Scientific Reports.

[12]  A. Ghaemi,et al.  Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus , 2017, Archives of Virology.

[13]  N. Garçon,et al.  From discovery to licensure, the Adjuvant System story , 2016, Human vaccines & immunotherapeutics.

[14]  D. Maria,et al.  Potential antitumor activity of novel DODAC/PHO-S liposomes , 2016, International journal of nanomedicine.

[15]  P. Leroueil,et al.  Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants , 2015, PloS one.

[16]  N. Garçon,et al.  Vaccine Adjuvants: from 1920 to 2015 and Beyond , 2015, Vaccines.

[17]  M. Battegay,et al.  IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza , 2014, PLoS pathogens.

[18]  E. Fixman,et al.  Adjuvant-dependent regulation of interleukin-17 expressing γδ T cells and inhibition of Th2 responses in allergic airways disease , 2014, Respiratory Research.

[19]  Su He Wang,et al.  Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity. , 2014, Molecular pharmaceutics.

[20]  T. Ebensen,et al.  Vaccine adjuvants: key tools for innovative vaccine design. , 2013, Current topics in medicinal chemistry.

[21]  W. Sessa,et al.  Differential regulation of cell functions by CSD peptide subdomains , 2013, Respiratory Research.

[22]  S. Streatfield,et al.  Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults , 2012, Viruses.

[23]  C. Andrews,et al.  Interleukin-17 Contributes to Generation of Th1 Immunity and Neutrophil Recruitment during Chlamydia muridarum Genital Tract Infection but Is Not Required for Macrophage Influx or Normal Resolution of Infection , 2010, Infection and Immunity.

[24]  M. Magnani,et al.  The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice. , 2010, Vaccine.

[25]  K. Musiychuk,et al.  Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. , 2009, Vaccine.

[26]  K. Musiychuk,et al.  Plant-expressed HA as a seasonal influenza vaccine candidate. , 2008, Vaccine.

[27]  C. Bode,et al.  CpG DNA as a vaccine adjuvant , 2003, Expert review of vaccines.

[28]  M. Muszkat,et al.  Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine. , 2003, Vaccine.

[29]  R. Hellens,et al.  pGreen: a versatile and flexible binary Ti vector for Agrobacterium-mediated plant transformation , 2000, Plant Molecular Biology.

[30]  K. Bergmann,et al.  Age-dependent antibody response in mice and humans following oral influenza immunization , 1987, Journal of Clinical Immunology.

[31]  J. Pedersen.  Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus. , 2014, Methods in molecular biology.